SCHEMBL767548

SCHEMBL767548

CC(C)CCC[C@@H](C)[C@H]1CCC2C3CC=C4CC(OC(=O)Oc5ccccc5)CC[C@]4(C)C3CC[C@@]21C

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLA1 P09884 1/20 0.73
CYP46A1 Q9Y6A2 2/20 0.69
OSBP P22059 3/20 0.65
USP2 O75604 2/20 0.65
RORC P51449 2/20 0.65
LMNA P02545 1/20 0.65
ABCB1 P08183 1/20 0.65
OSBP2 Q969R2 1/20 0.65
NPC1 O15118 1/20 0.59
CYP1A2 P05177 1/20 0.58
NR1H3 Q13133 3/20 0.58
NPC1L1 Q9UHC9 2/20 0.57
EPHA2 P29317 2/20 0.56
GBA1 P04062 2/20 0.56
UGCG Q16739 2/20 0.56
GBA2 Q9HCG7 2/20 0.56
GRIN1 Q05586 1/20 0.56
GRIN2A Q12879 1/20 0.56
PLA2G2A P14555 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246635 1.00 POLA1 (0.73) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL246636 1.00 POLA1 (0.73) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL11563103 0.94 POLA1 (0.65) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL11563100 0.94 POLA1 (0.65) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL12290965 0.94 POLA1 (0.69) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL137969 0.92 POLA1 (0.79) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL6419070 0.92 POLA1 (0.79) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL25352991 0.92 POLA1 (0.66) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL8097151 0.92 POLA1 (0.66) POLA1CYP46A1OSBPUSP2RORC
SCHEMBL2565939 0.92 POLA1 (0.66) POLA1CYP46A1OSBPUSP2RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10029127-B2 Anhydrous antisun cream comprising a non-emulsifying elastomeric organopolysiloxane, a matting agent and a non-silicone organic oil thickener L'OREAL (FR) 2018-07-24 US disclosed
US-8980240-B2 Eyelash makeup and/or care assembly L'OREAL (FR) 2015-03-17 US disclosed
US-20140178317-A1 ANHYDROUS ANTISUN CREAM COMPRISING A NON-EMULSIFYING ELASTOMERIC ORGANOPOLYSILOXANE, A MATTING AGENT AND A NON-SILICONE ORGANIC OIL THICKENER L'OREAL (FR) 2014-06-26 US disclosed
US-8404794-B2 Liquid crystal compositions E I DU PONT DE NEMOURS AND COMPANY (US) 2013-03-26 US disclosed
US-8344175-B2 Liquid crystal compositions, polymer networks derived therefrom and process for making the same E I DU PONT DE NEMOURS AND COMPANY (US) 2013-01-01 US disclosed
WO-2012168102-A2 ANHYDROUS ANTISUN CREAM COMPRISING A NON-EMULSIFYING ELASTOMERIC ORGANOPOLYSILOXANE, A MATTING AGENT AND A NON-SILICONE ORGANIC OIL THICKENER L'OREAL (FR) 2012-12-13 WO disclosed
US-20120104316-A1 LIQUID CRYSTAL COMPOSITIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-05-03 US disclosed
EP-2440632-A2 LIQUID CRYSTAL COMPOSITIONS E. I. du Pont de Nemours and Company (US) 2012-04-18 EP disclosed
EP-2440631-A1 LIQUID CRYSTAL COMPOSITIONS E. I. du Pont de Nemours and Company (US) 2012-04-18 EP disclosed
US-20120071618-A1 LIQUID CRYSTAL COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-03-22 US disclosed
US-20100308270-A1 LIQUID CRYSTAL COMPOSTIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-12-09 US disclosed
US-20100308268-A1 LIQUID CRYSTAL COMPOSITIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-12-09 US disclosed
US-20100308265-A1 LIQUID CRYSTAL COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-12-09 US disclosed
US-20100308269-A1 LIQUID CRYSTAL COMPOSITIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-12-09 US disclosed
US-20100031969-A1 EYELASH MAKEUP AND/OR CARE ASSEMBLY L'OREAL (FR) 2010-02-11 US disclosed
CN-101415797-A Liquid crystal compositions, polymer networks derived therefrom and process for making the same DU PONT (US) 2009-04-22 CN disclosed
EP-2001974-A1 LIQUID CRYSTAL COMPOSITIONS, POLYMER NETWORKS DERIVED THEREFROM AND PROCESS FOR MAKING THE SAME E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-12-17 EP disclosed
WO-2007120458-A1 LIQUID CRYSTAL COMPOSITIONS, POLYMER NETWORKS DERIVED THEREFROM AND PROCESS FOR MAKING THE SAME E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-10-25 WO disclosed
US-20070228326-A1 Liquid crystal compositions, polymer networks derived therefrom and process for making the same E. I. DU PONT DE NEMOURS AND COMPANY 2007-10-04 US disclosed
US-4140016-A CHOLESTERIC LIQUID CRYSTAL THERMOMETERS, BENZOIC ESTER DERIVATIVES BECTON, DICKINSON AND COMPANY (US) 1979-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100308265-A1 LIQUID CRYSTAL COMPOSITIONS CNOT9, AQP3, AQP1 POLA1 1326/4885CYP46A1 2900/4885OSBP 3849/4885
US-20100308270-A1 LIQUID CRYSTAL COMPOSTIONS TTR, CNOT9, CNOT7 POLA1 570/4885CYP46A1 756/4885OSBP 3668/4885
US-20100031969-A1 EYELASH MAKEUP AND/OR CARE ASSEMBLY KRT18, FLNA, F7 POLA1 1163/4885CYP46A1 3279/4885OSBP 772/4885
US-10029127-B2 Anhydrous antisun cream comprising a non-emulsifying elastomeric organopolysiloxane, a matting agent and a non-silicone organic oil thickener CUTA, AUP1, DDOST POLA1 655/4885CYP46A1 245/4885OSBP 35/4885
US-20140178317-A1 ANHYDROUS ANTISUN CREAM COMPRISING A NON-EMULSIFYING ELASTOMERIC ORGANOPOLYSILOXANE, A MATTING AGENT AND A NON-SILICONE ORGANIC OIL THICKENER CUTA, AUP1, DDOST POLA1 655/4885CYP46A1 245/4885OSBP 35/4885
US-20120071618-A1 LIQUID CRYSTAL COMPOSITIONS CNOT9, AQP3, AQP1 POLA1 1326/4885CYP46A1 2900/4885OSBP 3849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.